Gujarat Alkalies Mixes Cautious Q4 With Fresh Capex And A Hefty Dividend

Gujarat Alkalies and Chemicals has put out a busy set of updates: a modestly profitable March quarter, a new specialty capex bet and a generous dividend. The company reported March quarter consolidated revenue from operations of 11.25 billion rupees and consolidated profit of 149.8 million rupees, even as the board cleared a 670 million rupees investment for a 5,000 tonnes per annum high purity hydrogen peroxide plant at Dahej and recommended a dividend of 17.70 rupees per equity share for FY 2025 26. It is a combination that speaks of a commodity chemicals player trying to move up the value curve while still keeping its shareholder friendly credentials intact.

Quarterly Performance And Profitability  

With 11.25 billion rupees in consolidated revenue from operations, Gujarat Alkalies continues to see steady traction across its core chlor alkali and derivative portfolio. The consolidated profit of 149.8 million rupees, while not spectacular, suggests the company has managed to stay in the black through a patch of margin pressure and price normalisation after the earlier chemicals upcycle.  

New Hydrogen Peroxide Capex At Dahej  

The board’s approval for a 5,000 TPA high purity hydrogen peroxide plant at Dahej, with a capex outlay of 670 million rupees, is a clear tilt towards higher value, niche products. High purity hydrogen peroxide finds use in electronics, pharmaceuticals and specialised industrial applications, and this move positions Gujarat Alkalies to tap into more premium demand pockets rather than relying solely on bulk chlor alkali volumes.  

Dividend Signals Confidence  

Alongside the capex and a modest profit base, the recommendation of a 17.70 rupees per share dividend stands out. It indicates management’s confidence that balance sheet strength and internal accruals are adequate to fund both growth projects and shareholder payouts, an equilibrium long term investors tend to reward in cyclical chemicals names.  

Investor Focus And Outlook  

From here, the street will be watching timelines and returns from the Dahej hydrogen peroxide project, how quickly margins stabilise across the broader portfolio, and whether this level of dividend is sustainable if the cycle remains softer. Order visibility in end user industries, input cost trends and any signs of pricing power in higher value products will be the big variables.  

Key Highlights  

• March quarter consolidated revenue from operations at 11.25 billion rupees  
• March quarter consolidated profit at 149.8 million rupees  
• Board approves 670 million rupees capex for 5,000 TPA high purity hydrogen peroxide plant at Dahej  
• Board recommends dividend of 17.70 rupees per equity share for FY ended March 31, 2026  

Sources: Company March quarter consolidated financial disclosure, capex approval note and board communication on FY 2025 26 dividend recommendation